{"id":"https://genegraph.clinicalgenome.org/r/f76cfc60-7fef-44e9-b3c9-1b6d4e6b06c2v1.1","type":"EvidenceStrengthAssertion","dc:description":"*CAV1* was first reported in relation to autosomal dominant pulmonary arterial hypertension in 2012 (Austin ED et al., PMID: 22474227). Pulmonary Arterial Hypertension is a group of diseases characterized by elevated pulmonary arterial resistance leading to right heart failure.\nAs the genetic variants associated with lipodystrophies are different from those associated with H/IPAH ((with the exception of one reported case of a heterozygous C-terminal frameshift variant, c.479_480del; p.(Phe160Ter), identified in an individual with PAH and severe neonatal progeroid lipodystrophy syndrome (PMIDs: 26176221 and 25898808)), and the molecular mechanisms are likely to be different, *CAV1* was curated independently by both the PH GCEP and the monogenic diabetes GCEP, and both curations are available on the ClinGen website.\nSummary of Genetic Evidence: Three frameshift and five missense variants have been found in nine probands across five publications (PMIDs: 22474227, 29631995, 30578383, 31727138, 33007923). The mechanism of pathogenicity seems to be dominant negative. \nSummary of Experimental Evidence: This gene-disease association is also supported by biochemical function, functional alteration in patient cells, animal models and non-human model rescue studies (PMIDs: 16537870, 28904206, 28468941, 12177436, 17893196).  CAV1 is expressed in lung endothelial and smooth muscle cells, and expression is decreased or absent in plexiform lesions. Investigation of patient fibroblasts expressing a *CAV1* c.474delA variant demonstrated reduced caveolae density and caveolar protein levels, and expression of the mutant protein caused reduced wild-type protein. These data are consistent with a dominant negative mechanism of disease. Further, the increased SMAD1/5/8 phosphorylation observed in *CAV1* patient fibroblasts was not rescued by transduction with wild-type *CAV1*, arguing against haploinsufficiency as the pathogenetic mechanism. Finally, *CAV1* knockout mice, but interestingly not patients with homozygous null variants (PMIDs: 34643546 and 18211975), exhibit pulmonary vascular remodeling and features consistent with PAH, including higher pulmonary artery pressure, greater pulmonary vascular resistance, enhanced basal vascular permeability and RV hypertrophy; and the phenotype is largely rescued by endothelial re-expression of *CAV1*. In summary, *CAV1* is definitively associated with autosomal dominant pulmonary arterial hypertension. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. The PH GCEP approved this classification on 8/30/2022 (SOP v9.0).\n \nAdministrative edits and additional citations were added on 7/30/2025.\n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f76cfc60-7fef-44e9-b3c9-1b6d4e6b06c2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:summaryChange"},{"id":"cg:sopChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10071","date":"2025-07-30T22:59:02.769Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10071","date":"2025-07-30T16:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e7f1e43-a37e-4dc1-800b-337901535310","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e7f1e43-a37e-4dc1-800b-337901535310_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30578383","allele":{"id":"https://genegraph.clinicalgenome.org/r/4d301d45-fdda-4dbe-999a-9022a4d47e3c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.336_338del (p.Leu113del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573332052"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/69371b0a-f90c-464e-84cf-5b0ad55a4c49","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69371b0a-f90c-464e-84cf-5b0ad55a4c49_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/b60d07cc-a9a8-4020-8586-e86fdfff7f95","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.511C>T (p.Arg171Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4447899"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/642a8c3a-74f0-40c3-a507-864ba57f8498","type":"EvidenceLine","dc:description":"Variant was identified in her clinically unaffected father. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/642a8c3a-74f0-40c3-a507-864ba57f8498_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22474227","allele":{"id":"https://genegraph.clinicalgenome.org/r/41156759-21d1-48fc-b3de-f146abe23985","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.463G>A (p.Val155Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4447892"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6a6cff36-0415-498a-8736-ff39dd757a4d","type":"EvidenceLine","dc:description":"No functional data to support variant","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a6cff36-0415-498a-8736-ff39dd757a4d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/710abed8-4d06-44f8-9594-12880b171cf1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.474del (p.Leu159SerfsTer22)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA211293"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a0720ce3-f93a-4710-967a-4fec5c069862","type":"EvidenceLine","dc:description":"Several family members with normal physical examination and without detectable PAH also carry this variant. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0720ce3-f93a-4710-967a-4fec5c069862_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22474227","allele":{"id":"https://genegraph.clinicalgenome.org/r/710abed8-4d06-44f8-9594-12880b171cf1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a423a267-414f-49cd-ac69-e7c4d1dc7b4c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a423a267-414f-49cd-ac69-e7c4d1dc7b4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22474227","allele":{"id":"https://genegraph.clinicalgenome.org/r/5987035f-21c4-418b-9287-a5674c73adc3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.473del (p.Pro158HisfsTer23)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575593"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b3177f7d-fe0c-4816-a2c4-9895e7fecd9f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3177f7d-fe0c-4816-a2c4-9895e7fecd9f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33007923","allele":{"id":"https://genegraph.clinicalgenome.org/r/b60d07cc-a9a8-4020-8586-e86fdfff7f95"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b1a71494-6f9d-44cc-a629-63d8d3bdb19b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1a71494-6f9d-44cc-a629-63d8d3bdb19b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/f084db23-8009-4d4b-8428-62b6b7aeb76d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.284C>T (p.Thr95Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4447860"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ab05ddaf-d37e-4b90-b818-4c83911c73de","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab05ddaf-d37e-4b90-b818-4c83911c73de_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31727138","allele":{"id":"https://genegraph.clinicalgenome.org/r/a91196d7-0002-4785-bdd9-f5c7418207f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001753.5(CAV1):c.302G>A (p.Arg101His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4447863"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3b5df8e5-06ab-44f8-9414-5ae5522700bd","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b5df8e5-06ab-44f8-9414-5ae5522700bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29631995","allele":{"id":"https://genegraph.clinicalgenome.org/r/5987035f-21c4-418b-9287-a5674c73adc3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a676548b-57e0-4ad5-b766-d757c99f1840","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f14816ec-d454-43d3-8df3-fe82329e6767","type":"Finding","dc:description":"PAH associated phenotypes: right ventricular hypertrophy, elevation of mean pulmonary arterial pressure, pulmonary vascular resistance, right heart failure.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16537870","rdfs:label":"Achcar Biochemical Function Experiment","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c0a78fd-df0e-4bd2-9ffb-2a572f1721cd","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/737d35d4-6f64-4d48-8544-a89feff51a8e","type":"FunctionalAlteration","dc:description":"The density of caveolae and caveolar protein levels were reduced in patient fibroblasts expressing the c.474delA variant in CAV1","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28904206","rdfs:label":"Copeland Functional Alteration Experiment - Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/40d3ebe5-8aa7-4e52-ae2d-27494aacbfcf","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09d140b5-6fa8-4c91-bd79-3c6aede306b6","type":"FunctionalAlteration","dc:description":"Cav1* fibroblasts proliferated at a twofold higher rate than control fibroblasts. Collagen secretion was increased by 20% in Cav1* human fibroblasts compared with control fibroblasts. Treatment of cells with TGFÎ² increased collagen secretion by 30% in control fibroblasts but had minimal effect on Cav1* fibroblasts. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28468941","rdfs:label":"Marsboom Functional Alteration Experiment - Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1f4c3d64-7993-4196-a002-6cc9904a4360_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6783d32c-c674-4f8d-9d86-c100061a12ee","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0762057b-75ae-466a-b01d-845a724524f6","type":"Finding","dc:description":"Reexpression of CAV1 in endothelium rescued the vascular, cardiac, and pulmonary defects in the CAV1 knockout mice","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17893196","rdfs:label":"Murata Rescue Experiment - Non Human Model Organism ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bdd5ae78-d137-412d-8a3f-a408b08dbda8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28cc8c8c-cc61-4cb0-b03c-d4f4cc85dcee","type":"Finding","dc:description":"Cav1 knockout mice have phenotypes that are consistent with those of PAH.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12177436","rdfs:label":"Zhao Non Human Model Organism Experiment ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":10893,"specifiedBy":"GeneValidityCriteria11","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/m3BYCwqZcb8","type":"GeneValidityProposition","disease":"obo:MONDO_0015924","gene":"hgnc:1527","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1f4c3d64-7993-4196-a002-6cc9904a4360-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}